EUDA Health (NASDAQ:EUDA) Shares Scheduled to Reverse Split on Monday, March 23rd

Shares of EUDA Health Holdings Limited (NASDAQ:EUDA) are going to reverse split on Monday, March 23rd. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, March 22nd.

EUDA Health Stock Performance

Shares of EUDA stock traded down $0.07 on Thursday, hitting $0.40. 472,240 shares of the company’s stock traded hands, compared to its average volume of 149,615. The stock has a market capitalization of $15.07 million, a price-to-earnings ratio of -3.32 and a beta of -0.11. The company’s fifty day simple moving average is $1.11 and its 200 day simple moving average is $1.93. EUDA Health has a one year low of $0.36 and a one year high of $4.30.

Analysts Set New Price Targets

EUDA has been the topic of several analyst reports. Greenridge Global decreased their price objective on EUDA Health from $6.00 to $2.75 and set a “buy” rating on the stock in a report on Monday, March 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a report on Friday, January 9th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $2.75.

Institutional Trading of EUDA Health

An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new position in EUDA Health Holdings Limited (NASDAQ:EUDA) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned 0.07% of EUDA Health at the end of the most recent reporting period. 4.35% of the stock is owned by institutional investors.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.